The Asia Pacific Opioids Market would witness market growth of 3.5% CAGR during the forecast period (2021-2027).
Synthetic opioids (e.g., morphine and codeine) impact the same regions of the brain as natural opioids (e.g., morphine and codeine) to provide analgesic (pain-relieving) effects. Natural opioids, on the other hand, are naturally occurring compounds derived from the seed pods of specific poppy types. Fentanyl and methadone, for example, are synthetic opioids that have been approved for medicinal usage. In the late 1970s and 1980s, illicitly manufactured synthetic opioids structurally linked to the Schedule II opioid painkiller fentanyl were trafficked and misused on the West Coast. DEA controlled alphamethylfentanyl, 3-methylthiofentanyl, acetyl-alphamethylfentanyl, beta-hydroxy-3-methylfentanyl, alpha-methylthiofentanyl, thiofentanyl, betahydroxyfentanyl, para-fluorofentanyl, and 3-methylfentanyl in the 1980s.
Chronic pain is long-term pain that lasts longer than the normal recovery period or comes in conjunction with a chronic health condition like arthritis. Chronic pain can be intermittent or persistent. It may cause people to be unable to work, eat well, engage in physical activity, or simply enjoy life.
China is the world's second-largest pharmaceutical market, and it's flourishing due to two major factors: large-scale capital investment and strong increases in productivity. These two variables suggest that the country will be a desirable investment destination as well as a source of huge local savings. The country has been transitioning from a low-income to a more market-oriented economy since the 1970s. Due to its large-scale manufacturing capacity and high opioid consumption, China is witnessing a surge in the regional market. In recent years, both large and small pharmaceutical companies have made significant investments in research and development. Since most medications in the pipeline are nearing completion and will be ready by the end of the decade, opioid demand is expected to rise. In underdeveloped countries, it is easier to find patients for clinical studies.
The China market dominated the Asia Pacific Opioids Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $421.2 million by 2027. The Japan market is poised to grow at a CAGR of 2.9% during (2021 - 2027). Additionally, The India market would witness a CAGR of 4.3% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Opioids Market is Projected to reach USD 5.4 Billion by 2027, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Pain Management
- Cough Treatment and
- Diarrhea Treatment
By Product Type
- Methadone
- Oxycodone
- Hydrocodone
- Fentanyl
- Codeine
- Morphine and
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Opioids Market, by Application
1.4.2 Asia Pacific Opioids Market, by Product Type
1.4.3 Asia Pacific Opioids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Opioids Market by Application
3.1 Asia Pacific Pain Management Market by Country
3.2 Asia Pacific Cough Treatment Market by Country
3.3 Asia Pacific Diarrhea Treatment Market by Country
Chapter 4. Asia Pacific Opioids Market by Product Type
4.1 Asia Pacific Methadone Market by Country
4.2 Asia Pacific Oxycodone Market by Country
4.3 Asia Pacific Hydrocodone Market by Country
4.4 Asia Pacific Fentanyl Market by Country
4.5 Asia Pacific Codeine Market by Country
4.6 Asia Pacific Morphine Market by Country
4.7 Asia Pacific Other Product Type Market by Country
Chapter 5. Asia Pacific Opioids Market by Country
5.1 China Opioids Market
5.1.1 China Opioids Market by Application
5.1.2 China Opioids Market by Product Type
5.2 Japan Opioids Market
5.2.1 Japan Opioids Market by Application
5.2.2 Japan Opioids Market by Product Type
5.3 India Opioids Market
5.3.1 India Opioids Market by Application
5.3.2 India Opioids Market by Product Type
5.4 South Korea Opioids Market
5.4.1 South Korea Opioids Market by Application
5.4.2 South Korea Opioids Market by Product Type
5.5 Singapore Opioids Market
5.5.1 Singapore Opioids Market by Application
5.5.2 Singapore Opioids Market by Product Type
5.6 Malaysia Opioids Market
5.6.1 Malaysia Opioids Market by Application
5.6.2 Malaysia Opioids Market by Product Type
5.7 Rest of Asia Pacific Opioids Market
5.7.1 Rest of Asia Pacific Opioids Market by Application
5.7.2 Rest of Asia Pacific Opioids Market by Product Type
Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
TABLE 1 Asia Pacific Opioids Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Opioids Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Opioids Market by Application, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Opioids Market by Application, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Pain Management Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Pain Management Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Cough Treatment Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Cough Treatment Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Methadone Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Methadone Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Oxycodone Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Oxycodone Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Hydrocodone Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Hydrocodone Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Fentanyl Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Fentanyl Market by Country, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Codeine Market by Country, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Codeine Market by Country, 2021 - 2027, USD Million
TABLE 23 Asia Pacific Morphine Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Morphine Market by Country, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Other Product Type Market by Country, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Opioids Market by Country, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Opioids Market by Country, 2021 - 2027, USD Million
TABLE 29 China Opioids Market, 2017 - 2020, USD Million
TABLE 30 China Opioids Market, 2021 - 2027, USD Million
TABLE 31 China Opioids Market by Application, 2017 - 2020, USD Million
TABLE 32 China Opioids Market by Application, 2021 - 2027, USD Million
TABLE 33 China Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 34 China Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 35 Japan Opioids Market, 2017 - 2020, USD Million
TABLE 36 Japan Opioids Market, 2021 - 2027, USD Million
TABLE 37 Japan Opioids Market by Application, 2017 - 2020, USD Million
TABLE 38 Japan Opioids Market by Application, 2021 - 2027, USD Million
TABLE 39 Japan Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 40 Japan Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 41 India Opioids Market, 2017 - 2020, USD Million
TABLE 42 India Opioids Market, 2021 - 2027, USD Million
TABLE 43 India Opioids Market by Application, 2017 - 2020, USD Million
TABLE 44 India Opioids Market by Application, 2021 - 2027, USD Million
TABLE 45 India Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 46 India Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 47 South Korea Opioids Market, 2017 - 2020, USD Million
TABLE 48 South Korea Opioids Market, 2021 - 2027, USD Million
TABLE 49 South Korea Opioids Market by Application, 2017 - 2020, USD Million
TABLE 50 South Korea Opioids Market by Application, 2021 - 2027, USD Million
TABLE 51 South Korea Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 52 South Korea Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 53 Singapore Opioids Market, 2017 - 2020, USD Million
TABLE 54 Singapore Opioids Market, 2021 - 2027, USD Million
TABLE 55 Singapore Opioids Market by Application, 2017 - 2020, USD Million
TABLE 56 Singapore Opioids Market by Application, 2021 - 2027, USD Million
TABLE 57 Singapore Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 58 Singapore Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 59 Malaysia Opioids Market, 2017 - 2020, USD Million
TABLE 60 Malaysia Opioids Market, 2021 - 2027, USD Million
TABLE 61 Malaysia Opioids Market by Application, 2017 - 2020, USD Million
TABLE 62 Malaysia Opioids Market by Application, 2021 - 2027, USD Million
TABLE 63 Malaysia Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 64 Malaysia Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 65 Rest of Asia Pacific Opioids Market, 2017 - 2020, USD Million
TABLE 66 Rest of Asia Pacific Opioids Market, 2021 - 2027, USD Million
TABLE 67 Rest of Asia Pacific Opioids Market by Application, 2017 - 2020, USD Million
TABLE 68 Rest of Asia Pacific Opioids Market by Application, 2021 - 2027, USD Million
TABLE 69 Rest of Asia Pacific Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 70 Rest of Asia Pacific Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 71 Key information –Johnson and Johnson
TABLE 72 Key Information – AstraZeneca PLC
TABLE 73 Key Information – Boehringer Ingelheim International GmbH
TABLE 74 key Information – Endo International PLC
TABLE 75 Key information – Mallinckrodt PLC
TABLE 76 Key Information – Sanofi S.A.
TABLE 77 Key Information – Pfizer, Inc.
TABLE 78 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 80 Key Information – Purdue Pharma L.P.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.